Jim Cramer's Mad Money Review
Fallen Angel: VF. Corp (NYSE: VFC - News)
Cramer discussed "fallen angels" or stocks which deserve to trade at a higher multiple, but are down because of the market's stupidity. Cramer appaluds VFC's move in selling its "horrible" intimate apparel business which had "razor-thin margins" in order to let its more successful businesses thrive. However, investors did not hear this good news and instead paid too much attention to the company's disappointment with its fourth quarter and consequently "threw it down the pit." The stock dropped 7%, but Cramer predicts that it will miss its quarter by a mere three cents, and it should return to where it was and go higher after it reports on February 6.
Bad Press for Amgen (NasdaqGS: AMGN)
Cramer's second fallen angel, Amgen, was the victim of a negative headline which alleged that its Aranesp drug was potentially fatal when the patients who died were not expected to recover, regardless of the medicine. Low guidance was another factor in the stock's slip, but Cramer says that AMGN historically is conservative with guidance and expects to see an upside surprise. In addition, he notes that the company has drugs for osteoperosis and colon cancer in the pipeline.
Oxford Blues: Quest Diagnostic (NYSE: DGX - News), United Health (NYSE: UNH - News)
Cramer's third fallen angel is DGX, which fell apparently on the news of its split with Oxford Health, but Cramer believes that this factor was already built into the price. Cramer would buy DGX now, since it reported a good quarter and is cheap because of its low guidance. Although DGX thinks it will lose UNH, since UNH owns Oxford, Cramer does not believe this will happen and suspects DGX of low-balling, and predicts lackluster expectations will cause the stock to soar.CEO Interview, Peter van Stolk, Jones' Soda (JDSA)
Cramer asked Peter van Stolk if Jones' increase should continue now that its exclusive soda contract with Target has expired. While van Stolk commented that Target is a great retailer and that he expects to continue working with them, new opportunities should cause the stock to ramp. One of Jones' major selling points is that it uses pure cane sugar rather than corn syrup."Corn is for cars, and sugar is for sodas," he quipped. Since Jones has had a "monster move," Cramer would wait for it to come down a bit before buying.
Published By SeekingAlpha
posted by Stock Administrator @ 7:35 AM
0 Comments
Jim Cramer's Mad Money Review
Fallen Angel: VF. Corp (NYSE: VFC - News)
Cramer discussed "fallen angels" or stocks which deserve to trade at a higher multiple, but are down because of the market's stupidity. Cramer appaluds VFC's move in selling its "horrible" intimate apparel business which had "razor-thin margins" in order to let its more successful businesses thrive. However, investors did not hear this good news and instead paid too much attention to the company's disappointment with its fourth quarter and consequently "threw it down the pit." The stock dropped 7%, but Cramer predicts that it will miss its quarter by a mere three cents, and it should return to where it was and go higher after it reports on February 6.
Bad Press for Amgen (NasdaqGS: AMGN)
Cramer's second fallen angel, Amgen, was the victim of a negative headline which alleged that its Aranesp drug was potentially fatal when the patients who died were not expected to recover, regardless of the medicine. Low guidance was another factor in the stock's slip, but Cramer says that AMGN historically is conservative with guidance and expects to see an upside surprise. In addition, he notes that the company has drugs for osteoperosis and colon cancer in the pipeline.
Oxford Blues: Quest Diagnostic (NYSE: DGX - News), United Health (NYSE: UNH - News)
Cramer's third fallen angel is DGX, which fell apparently on the news of its split with Oxford Health, but Cramer believes that this factor was already built into the price. Cramer would buy DGX now, since it reported a good quarter and is cheap because of its low guidance. Although DGX thinks it will lose UNH, since UNH owns Oxford, Cramer does not believe this will happen and suspects DGX of low-balling, and predicts lackluster expectations will cause the stock to soar.CEO Interview, Peter van Stolk, Jones' Soda (JDSA)
Cramer asked Peter van Stolk if Jones' increase should continue now that its exclusive soda contract with Target has expired. While van Stolk commented that Target is a great retailer and that he expects to continue working with them, new opportunities should cause the stock to ramp. One of Jones' major selling points is that it uses pure cane sugar rather than corn syrup."Corn is for cars, and sugar is for sodas," he quipped. Since Jones has had a "monster move," Cramer would wait for it to come down a bit before buying.
Published By SeekingAlpha
Cramer discussed "fallen angels" or stocks which deserve to trade at a higher multiple, but are down because of the market's stupidity. Cramer appaluds VFC's move in selling its "horrible" intimate apparel business which had "razor-thin margins" in order to let its more successful businesses thrive. However, investors did not hear this good news and instead paid too much attention to the company's disappointment with its fourth quarter and consequently "threw it down the pit." The stock dropped 7%, but Cramer predicts that it will miss its quarter by a mere three cents, and it should return to where it was and go higher after it reports on February 6.
Bad Press for Amgen (NasdaqGS: AMGN)
Cramer's second fallen angel, Amgen, was the victim of a negative headline which alleged that its Aranesp drug was potentially fatal when the patients who died were not expected to recover, regardless of the medicine. Low guidance was another factor in the stock's slip, but Cramer says that AMGN historically is conservative with guidance and expects to see an upside surprise. In addition, he notes that the company has drugs for osteoperosis and colon cancer in the pipeline.
Oxford Blues: Quest Diagnostic (NYSE: DGX - News), United Health (NYSE: UNH - News)
Cramer's third fallen angel is DGX, which fell apparently on the news of its split with Oxford Health, but Cramer believes that this factor was already built into the price. Cramer would buy DGX now, since it reported a good quarter and is cheap because of its low guidance. Although DGX thinks it will lose UNH, since UNH owns Oxford, Cramer does not believe this will happen and suspects DGX of low-balling, and predicts lackluster expectations will cause the stock to soar.CEO Interview, Peter van Stolk, Jones' Soda (JDSA)
Cramer asked Peter van Stolk if Jones' increase should continue now that its exclusive soda contract with Target has expired. While van Stolk commented that Target is a great retailer and that he expects to continue working with them, new opportunities should cause the stock to ramp. One of Jones' major selling points is that it uses pure cane sugar rather than corn syrup."Corn is for cars, and sugar is for sodas," he quipped. Since Jones has had a "monster move," Cramer would wait for it to come down a bit before buying.
Published By SeekingAlpha
posted by Stock Administrator @ 7:35 AM
0 Comments
